Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.45 -0.01 (-2.17%)
At close: Nov 16, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Net Income towards Common Stockholders (2009 - 2026)

Updated

Protagenic Therapeutics, Inc.new's Net Income towards Common Stockholders came in at -$667,194 for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$869,496 a year earlier.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Protagenic Therapeutics, Inc.new reported Net Income towards Common Stockholders of $5.66 million; for FY2026 (ended Mar 31, 2026), it came in at $1.37 million.

  • Going back by fiscal year, Net Income towards Common Stockholders was -$3.59 million in FY2025, -$5.53 million in FY2024, -$5 million in FY2023 and -$3.56 million in FY2022.
  • The five-year range for quarterly Net Income towards Common Stockholders is -$5.06 million (fiscal Q1 2026) to $5.08 million (fiscal Q4 2026).
  • Business Quant data shows PTIX's Net Income towards Common Stockholders at -$963,616 (Q1 2027), $5.08 million (Q4 2026) and $2.21 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 210.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 4.22 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.12 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 2.43 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.24 Bn
10 Protagenic Therapeutics, Inc.new 850,797.76 -4.70 Mn - -667,194.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -667,194.00
Jun 30, 2026 -963,616.00
Mar 31, 2026 5.08 Mn
Dec 31, 2025 2.21 Mn
Sep 30, 2025 -869,496.00
Jun 30, 2025 -5.06 Mn
Mar 31, 2025 -1.44 Mn
Dec 31, 2024 -850,287.00
Sep 30, 2024 -582,387.00
Jun 30, 2024 -324,355.00
Mar 31, 2024 -1.72 Mn
Dec 31, 2023 -1.68 Mn
Sep 30, 2023 -1.40 Mn
Jun 30, 2023 -1.21 Mn
Mar 31, 2023 -718,096.00
Dec 31, 2022 -601,374.00
Sep 30, 2022 -925,305.00
Jun 30, 2022 -666,717.00
Mar 31, 2022 -1.36 Mn
Dec 31, 2021 -890,387.00
API Access

Protagenic Therapeutics, Inc.new Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PTIX&period=max&api_key=YOUR_API_KEY